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Distinguishing bacterial from viral meningitis/aseptic 
meningitis (VM/AM) is an age-old problem. Th  e  distinc-
tion is important because bacterial meningitis (BM) 
requires urgent intravenous antibiotic administration in 
the hospital whereas AM is self-limiting. A reliable and 
valid marker is necessary to make this distinction.
In the previous issue of Critical Care, Huy and 
colleagues [1] summarize data from 25 studies describing 
the test characteristics of cerebrospinal ﬂ  uid  (CSF) 
lactate in the diﬀ  erential diagnosis between acute BM 
and AM. Th   e methodology used by the authors is reason-
ably sound and inspires conﬁ   dence in the results. 
Reviewer bias was controlled with the use of two 
independent reviewers for selection of studies, data 
extraction, and quality assessment. Th  e  chance-corrected 
agreement (kappa = 0.898) between the reviewers was 
very high for study selection, although the same was not 
reported for data extraction and quality assessment.
Huy and colleagues used well-established criteria to 
assess the quality of the selected studies, and examined 
and explored heterogeneity using standard methods and 
summarized the results using a summary receiver 
operator characteristic (SROC) curve. Th  e authors pre-
sented Q value and area under the curve (AUC) as 
measures of accuracy. Th  e AUC of CSF lactate concen-
tration was 0.9840, indicating excellent accuracy. Th  e 
authors concluded that CSF lactate is a good single 
indicator to distinguish BM from AM and a better 
marker than other conventional markers. However, 
comments on threats to internal validity and generaliza-
bility of the ﬁ  ndings are warranted.
Threats to internal validity
Th   e quality of a meta-analysis can be only as good as the 
included studies (‘GIGO’ principle: garbage in, garbage 
out). Th   e quality of studies included in the review by Huy 
and colleagues is somewhat unsettling. Speciﬁ  cally, 
reported blinding of lactate assay in only 3 (13%) studies 
and consecutive or random recruitment of participants 
in 12 (50%) is a matter of concern. It is possible that other 
studies blinded the lactate assay without reporting the 
fact, but this matter remains speculative in the absence of 
conﬁ   rmation from the study authors. Compromised 
quality of original studies threatens the validity of the 
conclusions.
Lack of a proper ‘gold standard’ for AM or VM is a 
vexing problem in this area of research. When an 
imperfect standard is used to evaluate a diagnostic test, 
distortions occur in the commonly used measures of test 
performance, like sensitivity/speciﬁ   city [2]. Distorted 
measures carry the error in their meta-analysis. Th  is 
review suﬀ  ers from this error.
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© 2011 BioMed Central LtdTwo comments on the comparison of CSF lactate assay 
with conventional CSF markers are warranted. First, 
clinicians diagnose AM on the basis of a pattern of a 
combination of ﬁ  ndings on conventional CSF markers 
(CSF total number of leukocytes, CSF glucose, CSF/
plasma glucose quotient, and CSF protein), not on 
individual markers. Th  us, it is clinically relevant to 
compare this pattern and the CSF lactate assay and to 
determine whether the assay adds signiﬁ   cantly to the 
pattern. However, the authors did not address this 
question; this was probably because they did not have 
access to the individual patient data that are necessary to 
perform this comparison. Th  e review, therefore, fails to 
answer this question.
Second, the authors assert a lower accuracy of 
individual CSF markers compared with the CSF lactate 
test based on point estimates of AUC. It is not clear 
whether the observed diﬀ  erences in AUC are statistically 
signiﬁ  cant. An objective assessment of this is possible by 
using the Hanley test [3] and by calculating the 
conﬁ  dence interval around the estimates.
Applicability
CSF lactate assay is not available in most centers in 
developing countries and rural settings. Th   is and the fact 
that many patients receive antibiotics before lumbar 
puncture compromise the applicability of the ﬁ  ndings.
Summary
Th   e review is a worthwhile contribution to the ﬁ  eld, has a 
sound methodology, and provides a summary of the 
results from published data. Clearly, a meta-analysis of 
individual patient data and more studies are required to 
determine deﬁ   nitively whether CSF lactate assay is a 
reliable and valid marker to distinguish between BM and 
AM.
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